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Sphingolipids, including ceramides, are a diverse group of structurally related lipids composed of a 
sphingoid base backbone coupled to a fatty acid side chain and modified terminal hydroxyl group. 
Recently, it has been shown that sphingolipids show antimicrobial activity against a broad range of 
pathogenic microorganisms. The antimicrobial mechanism, however, remains so far elusive. Here, we 
introduce ‘click‑AT‑CLEM’, a labeling technique for correlated light and electron microscopy (CLEM) 
based on the super‑resolution array tomography (srAT) approach and bio‑orthogonal click chemistry 
for imaging of azido‑tagged sphingolipids to directly visualize their interaction with the model Gram‑
negative bacterium Neisseria meningitidis at subcellular level. We observed ultrastructural damage of 
bacteria and disruption of the bacterial outer membrane induced by two azido‑modified sphingolipids 
by scanning electron microscopy and transmission electron microscopy. Click‑AT‑CLEM imaging and 
mass spectrometry clearly revealed efficient incorporation of azido‑tagged sphingolipids into the 
outer membrane of Gram‑negative bacteria as underlying cause of their antimicrobial activity.
Sphingolipids, including ceramides, form a diverse group of structurally related lipids and are composed of a 
backbone of sphingoid bases coupled to a fatty acid side chain. A broad range of different head motives and 
complex glycosylation pattern results in further  variability1. Besides their important function as bio-effector 
molecules, which are involved in the regulation of various aspects of cell growth, proliferation, and in anti-
cancer  therapeutics2, several studies indicate a role of sphingoid bases and fatty acids in the defense against 
pathogenic  microorganisms3–5. The antimicrobial properties of host-derived lipids have become increasingly 
recognized in the  past6–8 and their use for anti-infective therapy and prophylactic approaches seems attractive. 
Human lipids with antimicrobial properties include free fatty acids, monoglycerides and sphingolipids, showing 
different degrees of antimicrobial activity against Gram-positive and Gram-negative  bacteria3,4,8–13. Whereas a 
recent study identified the mechanism of the bactericidal effect of sphingosine, by interaction with the bacterial 
membrane lipid cardiolipin leading to membrane  permeabilization14, the antimicrobial mechanism of azido-
modified sphingolipids is still unknown. A recent study demonstrated the antimicrobial activity of a synthetic 
ceramide analog against the Gram-negative bacterium Neisseria meningitidis, a major cause of septicemia and 
bacterial meningitis  worldwide15. Here the addition of a functional azido group to the omega position of the 
fatty acid chain side of a synthetic short chain ceramide-resulting in ω-azido-C6-ceramide [ω-N3-C6-ceramide, 
Cer (d18:1/6:0-ω-N3)]-induced efficient killing of N. meningitidis13,16. Importantly, the compound showed no 
cytotoxic effects on eukaryotic  cells13. However, it remains elusive if the observed antimicrobial effects are based 
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on the interaction of the modified sphingolipid with the bacterial membrane, or accumulation in the cytoplasm 
where it might interfere with the microbial metabolism.
Various imaging methods can be used to analyze the mode of action of antimicrobial agents and complement 
biophysical studies. The combination of high-resolution imaging with fluorescence imaging and refined labeling 
techniques paves the way for tracking and quantification of an antimicrobial compound throughout the cell.
In this study, we established a protocol based on a combination of correlative light and electron micros-
copy (CLEM), i.e. super-resolution array tomography (srAT)17,18 and click  chemistry19, which we call in short 
‘click-AT-CLEM’. This combination of fluorescence and electron imaging applied here to the Gram-negative 
bacterium N. meningitidis allowed to determine morphological and ultrastructural changes after treatment with 
azido-modified sphingolipid analogs as well as to visualize their subcellular localization. A dibenzocyclooctyne 
(DBCO)-containing fluorescent dye (Alexa Fluor 488 DIBO analog (AFDye 488 DBCO AF)) was used for 
fluorescent labeling of azido-tagged sphingolipid  analogs13,16,20–22 via Cu(I)-free strain-promoted alkyne-azide 
cycloaddition click chemistry reaction (SPAAC)23,24. Our data demonstrate that srAT technology in combination 
with click chemistry–based labeling reaction is ideally suited to visualize, track and quantify azido-modified 
antimicrobial sphingolipids in bacteria.
Results
Inhibitory and bactericidal activity of a novel sphingolipid analog, ω‑N3‑sphingosine, against N. 
meningitidis. We have recently documented minimal inhibitory and bactericidal concentration (MIC and 
MBC) values for the antimicrobial sphingolipid sphingosine as well as for short-chain and long-chain ceramides 
and several ceramide analogs, including α-N3-C6-ceramide, ω-N3-C6-ceramide, α-N3-C16-ceramide and ω-N3-
C16-ceramide, against the Gram-negative microorganism N. meningitidis by broth microdilution assays and time 
killing  studies13. The data demonstrated a potent bactericidal activity of sphingosine and the synthetic ceramide 
analog ω-N3-C6-ceramide against N. meningitidis13. Here, we now determined the MIC and MBC values for a 
newly synthesized sphingosine analog, ω-N3-sphingosine22, against N. meningitidis. ω-N3-sphingosine displayed 
a MIC value of 4 µg/ml and a MBC value of 8 µg/ml comparable to MIC/MBC values observed for the unmodi-
fied sphingosine for N. meningitidis (Table S1)13. In line with our previous study, we included Escherichia coli 
and Staphylococcus aureus as control organisms and MIC/MBC values of 16 µg/ml (MIC)/16 µg/ml (MBC) (for 
E. coli) and 8 µg/ml (MIC)/16 µg/ml (MBC) (for S. aureus) were determined (Table S1).
Functionalized sphingolipids induce concentration dependent membrane alteration and 
disruption in N. meningitidis. To investigate the effects of two azido-modified sphingolipids, ω-N3-
sphingosine and ω-N3-C6-ceramide, on N. meningitidis, bacteria were treated with different amounts of the 
two compounds and analyzed by scanning electron microscopy (SEM) and transmission electron microscopy 
(TEM). Azido-modified sphingolipids allowed imaging of sphingolipids in  prokaryotes13 via conventional fluo-
rescence  microscopy20 or high-resolution  microscopy13. As control, N. meningitidis were treated with ethanol 
(solvent control). Ethanol treated control N. meningitidis exhibited coccus morphology with typical ‘kidney 
or coffee-bean shape’ and SEM showed the characteristic pairs of N. meningitidis cells forming a diplococcus 
(Fig. 1C). Control bacteria showed a slight increase in their electron density by TEM, but no morphological 
changes compared to non-solvent treated bacteria (Fig. 1A–C, Fig. S1). In contrast, N. meningitidis treated with 
a functionalized ω-N3-sphingosine or a ω-N3-C6-ceramide were distorted to various degrees and their surfaces 
were wrinkled when treated with a concentration corresponding to 1 × MBC (Fig. 1G–I, N–P). Bacteria showed 
an increased number of external blebs in SEM sections. In addition, bacteria appeared in various stages of lysis 
with compromised cell wall and plasma membrane. Bacteria treated with a lower concentration of the function-
alized sphingolipids corresponding to 0.1 × MBC showed only a slight alteration of their surfaces and shape 
compared to control N. meningitidis.
In thin sections, control N. meningitidis showed the typical coccus morphology, the outer and inner mem-
brane and the release of outer membrane vesicles were visible (Fig. 1A-B). In N. meningitidis treated with 0.1 
× MBC of either ω-N3-sphingosine or ω-N3-C6-ceramide, some cells were still intact with an outer and inner 
membrane (Fig. 1D–F, K–M). In some bacteria, there was intact intracellular content, however with strong 
elongation of the outer membrane (Fig. 1E). N. meningitidis treated with 1 × MBC of both compounds showed 
different stages of disintegration and lysis (Fig. 1G,H,N,O). The cytoplasm was not uniform with flocculation and 
aggregation of intracellular contents. Bacteria showed intracellular inclusion bodies appearing in high electron 
density in electron micrographs and additional vesicles that filled the intracellular content (Fig. 1O).
We also investigated the effects of both azido-modified sphingolipids on E. coli und S. aureus by TEM analysis. 
Control S. aureus had a typical ‘coccus’ morphology and formed grape-like clusters (Fig. S2). S. aureus treated 
with ω-N3-C6-ceramide were unaffected and showed intact cell walls and the cytoplasmatic membranes were 
clearly visible (Fig. S2G,H). In line with this finding, when E. coli were treated with ω-N3-C6-ceramide bacteria 
were also unaffected, showed intact cell wall and membranes and the cytoplasm had a uniform granularity 
(Fig. S2E,F). In contrast, both S. aureus and E. coli treated with 1 × MBC of ω-N3-sphingosine were distorted 
to various degrees. ω-N3-sphingosine-treated E. coli showed electron dense intracellular inclusion bodies and 
additional vesicles that filled the intracellular content (Fig. S2A,B). Like that seen in E. coli, S. aureus treated 
with ω-N3-sphingosine also contained electron dense intracellular content and, in some bacteria, the remain-
ing cell wall and cytoplasm were not intact and an aggregation of flocculation of intracellular content appeared 
(Fig. S2C,D).
Click‑AT‑CLEM imaging reveals localization of azido‑functionalized sphingolipids in N. menin-
gitidis. While SEM/TEM-analysis allowed us to visualize the morphological and ultrastructural changes of 
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Figure 1.  TEM and SEM micrographs show the effect of N. meningitidis treated with azido-modified sphingolipids. Representative TEM 
or SEM images of N. meningitidis treated with either EtOH (A–C), 0.1/1 × MBC of ω-N3-sphingosine (D–F/G–I) or 0.1/1 × MBC of ω-N3-
C6-ceramide (K–M/N–P). N. meningitidis treated with 0.1 × MBC of ω-N3-sphingosine or ω-N3-C6-ceramide showed a slight alteration 
of their surfaces and shape (F,M) and intact intracellular content. However, some bacteria displayed a strong elongation of the outer 
membrane (E,L). N. meningitidis treated with 1 × MBC of ω-N3-sphingosine or ω-N3-C6-ceramide were distorted to various degrees and 
their surfaces were wrinkled (I,P). Many bacteria appeared in various stages of lysis with compromise of the cell wall and plasma membrane 
(G–I,N–P). Bacteria showed intracellular inclusion bodies appearing in high electron density (H,O, indicated with asterisks) in electron 
micrographs and additional vesicles that filled the intracellular content (O, indicated with arrowheads). First column: TEM overview 
images, scale bars 1 µm. Second column: TEM detail images, scale bars 0.25 µm. Third column: SEM detail images, scale bars 0.25 µm.
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the membrane and cell wall, we aimed to use a labeling protocol to track and quantify the sphingolipid distribu-
tion at subcellular level. As this is very challenging with established immunolabeling approaches for electron 
microscopy, we developed a novel pre-embedding correlative light and electron microscopy (CLEM) protocol to 
achieve a more precise localization of the uptake of the two azido-modified sphingolipids, ω-N3-sphingosine and 
ω-N3-C6-ceramide, by N. meningitidis. Recently, we successfully demonstrated that the toolkit of azido-modified 
sphingolipids can be used for imaging sphingolipids in mammalian  cells20 and  prokaryotes13 via conventional 
fluorescence  microscopy20 or high-resolution  microscopy13. Super-resolution array tomography (srAT)17,18,25,26 
is an antibody-based staining CLEM workflow that combines preparation of the samples for super-resolution 
microscopy (e.g. structural illumination microscopy (SIM)) followed by electron microscopy, LR-White embed-
ding and preparation of 100 nm ultrathin sections. Staining with sphingolipid specific antibodies, to detect only 
the incorporated sphingolipids, then takes place on the array of serial sections. Due to the embedding step prior 
to labeling, only a proportion of the epitopes are accessible to the staining protocol with antibodies, whereas a 
larger number of epitopes can be hidden in the resin making them inaccessible for the  antibody27.
In contrast, azido-functionalized sphingolipid analogs can be visualized and tracked directly by fluores-
cence microscopy. To overcome this limitation, we used the functional azido group coupled to the ω-position 
of sphingosine or the amine-bound fatty acid side chain of ceramides, respectively, utilizing a copper-free click 
chemistry reaction. A dibenzocyclooctyne (DBCO)-containing fluorescent dye [Alexa Fluor 488 DIBO analog 
(AFDye 488 DBCO AF)] was used for the fluorescent labeling, that has been tested to preserve its fluorescence 
embedded in the LR-White resin, thus allowing CLEM for super-resolution fluorescence analysis followed by 
EM preparation protocols. Due to the pre-embedding labeling, the entire cell surface was accessible for direct 
labeling with the dye and not only the parts of the cell membrane facing the section surface as it would be the 
case in post-embedding on-section staining. In addition, click chemistry allowed us to specifically stain only the 
sphingolipids, which becomes especially important due to the lack of lipid specific antibodies (Fig. 2).
To test the applicability of copper-free click chemistry for CLEM, bacteria were treated with different concen-
trations of ω-N3-C6-ceramide or ω-N3-sphingosine and labeled with AFDye 488 DBCO AF. Control cells that 
were not treated with functionalized sphingolipid analogs exhibited only minimal levels of unspecific background 
fluorescence after labeling with the dye (Fig. S3). Treatment of N. meningitidis with 0.1 × the MBC of ω-N3-
C6-ceramide and subsequent labeling with AFDye 488 DBCO AF showed a similar morphological pattern by 
CLEM and only a subset of bacteria was affected (Fig. 3a-ii). Whereas the majority of the bacteria still displayed 
an unaltered ‘kidney or coffee-bean shape’, some bacteria showed elongations of their outer membrane (Fig. 3a-
ii). In addition, all bacteria showed an unaffected cytosolic compartment with even dense content, which could 
also be seen on DNA staining images (Fig. 3a-iii). Interestingly, for some bacteria CLEM imaging revealed that 
dye-labeled ω-N3-C6-ceramide clearly integrated into the bacterial membrane and was found especially in the 
elongated outer membrane (Fig. 3a-i,iv). In contrast, treatment of N. meningitidis with 1 × the MBC of ω-N3-C6-
ceramide and subsequent dye labeling resulted in distortion of the bacteria to various degrees and condensation 
of electron dense material in the cytosol of bacteria (Fig. 3b-ii). Moreover, dye-labeled ω-N3-C6-ceramide could 
not be detected in the bacterial membrane (Fig. 3b). CLEM imaging revealed that the electron dense material 
clearly correlated with accumulation of the labeled sphingolipid analog.
Next, bacteria were treated with a low concentration of ω-N3-sphingosine (0.1 × the MBC) and subsequently 
labeled with AFDye 488 DBCO AF and imaged by CLEM. Treatment of N. meningitidis with 0.1 × the MBC of 
Figure 2.  Scheme of the click-AT-CLEM workflow. The scheme shows a breakdown of most important steps in 
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ω-N3-sphingosine showed a similar morphological pattern compared to bacteria treated with ω-N3-C6-ceramide. 
Again, only a minor proportion of bacteria was affected and some showed elongations of the outer membrane, 
whereas most of the bacteria remained unaltered in their morphology and showed continuous intracellular 
content (Fig. 4A-ii,iii).
CLEM imaging showed that the functionalized sphingolipid integrated into the membrane extensions and 
could barely be found in the cytosol of the bacteria (Fig. 4a-i,iv). When N. meningitidis were treated with 1 × 
the MBC of ω-N3-sphingosine and subsequently labeled with the dye, bacteria displayed a similar morphology 
compared to bacteria treated with the functionalized ω-N3-C6-ceramide without dye labeling and analyzed by 
SEM (Fig. 4b). Bacteria appeared in various stages of lysis with compromise of the cell wall, outer and inner 
membrane and demonstrated an altered shape compared to control bacteria (Fig. 4b-ii,iii). By SEM we observed 
a strong accumulation in the electron dense regions in the cytosol of the bacteria. By CLEM imaging we could 
clarify that the electron dense region correlated to staining with and accumulation of the dye labeled ω-N3-
sphingosine (Fig. 4b-i,iv).
Functionalized sphingolipids primarily affect the outer membrane of N. meningitidis as con-
firmed by mass spectrometry. Due to the lower resolution of the fluorescence imaging, compared to the 
electron microscopy, we aimed to confirm the indicated localization in the outer membrane, after low concen-
tration treatment, by HPLC–MS/MS. For that, we separated the inner and outer membrane of the bacteria after 
incubation with 0.1 × the MBC of either ω-N3-sphingosine or ω-N3-C6-ceramide and quantified the amount 
of functionalized lipids in the different membrane fractions (1–12). Both treatments show a similar picture in 
which the lactate dehydrogenase (LDH) activity, a marker for the inner membrane, decreases with the increasing 
fractions number (from 1 to 12), whereas the amount of the outer membrane protein OpcA increased (Fig. 5a,b). 
The amount of ω-N3-sphingosine (Fig. 5a) or ω-N3-C6-ceramide (Fig. 5b), measured in the same fractions that 
have been used for the fraction characterization, show a negative correlation with the LDH activity and a positive 
correlation with the OpcA amount. Classification of the fractions into inner membrane, intermediate and outer 
membrane was done with the ethanol (EtOH) treated control group, based on the LDH activity, and transferred 
to the treated samples (Fig. S4).
For ω-N3-sphingosine and ω-N3-C6-ceramide, fraction number 9 seemed to be the cleanest outer membrane 
fraction with the lowest LDH activity and the strongest OpcA signal. In this specific fraction, the amount of 
functionalized lipids was strongly increased, especially compared to the inner membrane fractions indicating 
the primary effect on the outer membrane. Of note, functionalized sphingolipids were quantified in relation to 
Figure 3.  Click-AT-CLEM strategy reveals localization of ω-N3-C6-Ceramid in N. meningitidis. (a,b) 
Representative CLEM images of N. meningitidis treated with 0.1 × MBC (a) or 1 × MBC (b) of ω-N3-C6-
ceramide. Upper rows show representative single images of the ω-N3-C6-ceramide [ω-N3-C6-Cer (green)] and 
DNA signal (magenta) taken with SIM (i,iii) and N. meningitidis image taken with SEM (ii). Final images after 
unbiased correlation are shown in (iv). Scale bars 1 µm.
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the canonical sphingolipid C16 sphingomyelin (C16 SM), a typical membrane lipid whose occurrence in mem-
brane fractions is most likely due to the medium used for cultivation of N. meningitidis strain MC58 (PPM+). 
HPLC–MS/MS experiments reveal that the medium contained 1.79 ± 0.01 pmol/ml C16 SM. Therefore, bac-
teria of the membrane separation experiment were exposed to 179 pmol C16 SM via the cultivation medium. 
It therefore seems plausible that the bacteria have absorbed the C16 SM detected in the membrane fractions 
(0.38–4.80 pmol/ml) from the medium and integrated it into their membranes. For an endogenous synthesis of 
sphingomyelins in N. meningitidis there is no evidence in the literature.
Figure 4.  Click-AT-CLEM strategy reveals localization of ω-N3-Sphingosin in N. meningitidis. (a,b) 
Representative CLEM images of N. meningitidis treated with 0.1 × MBC (a) or 1 × MBC (b) of ω-N3-
Sphingosine. Upper rows show representative single images of the ω-N3-sphingosine [ω-N3-Sph (green)] and 
DNA signal (magenta) taken with SIM (i,iii) and N. meningitidis image taken with SEM (ii). Final images after 
unbiased correlation are shown in (iv). Scale bars 1 µm.
Figure 5.  Quantification of azido-functionalized sphingolipid levels in membrane fractions of N. meningitidis 
by mass spectrometry. Characterization of membrane fractions (1–12) of N. meningitidis after treatment of 
bacteria with either ω-N3-sphingosine (a) or ω-N3-C6-ceramide (b). Each fraction was tested for LDH activity 
per µg protein (blue line), as inner membrane marker and OpcA abundance by dot blot (below X-axis) as outer 
membrane marker. Bars represent the amount of azido-functionalized sphingosine or ceramide, as determined 
by HPLC–MS/MS, normalized to the amount of C16 sphingomyelin (SM) found in the samples. LDH data show 
the mean ± SD of a representative experiment performed in duplicate.
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Discussion
In this study we observed that beside ω-N3-C6-ceramide16 an azido-modified sphingosine, ω-N3-sphingosine22, 
exhibited significant bactericidal activity. We show that an observable effect on bacteria of both modified sphin-
golipid analogs is distortion of the cell membrane. The introduced srAT technology in combination with click 
chemistry-based labeling reaction (Click-AT-CLEM) clearly revealed that the azido-modified sphingolipids 
localize to the outer membrane resulting in strong elongation of the outer membrane. Pre-embedding labeling 
as used in this study added another level of versatility to the srAT workflow. It enabled super-resolved localiza-
tion of incorporated fluorescent tags in the full ultrastructural background without on-section labelling that is 
normally necessary in AT  workflows25,26. This adds a level of simplification to the protocol as on section labelling 
steps are typically laborious and can be error  prone28–30. To verify our findings, we separated the outer and inner 
membrane of bacteria after treatment with ω-N3-C6-ceramide or ω-N3-sphingosine for qualitative observations 
by quantitative mass spectrometric measurements. Indeed, HPLC–MS/MS results confirmed the primarily effect 
of the azido-modified sphingolipids on the outer membrane of N. meningitidis.
Human lipids with antimicrobial properties include free fatty acids, monoglycerides and sphingolipids, and 
their activity against Gram-positive and Gram-negative bacteria have been demonstrated in various  studies3,4,8–13. 
Sphingolipids, including ceramides, form a diverse group of structurally related lipids and are composed of a 
backbone of sphingoid bases coupled to a fatty acid side chain. A broad range of different head motives and 
complex glycosylation pattern results in further  variability1. Sphingoid bases and certain fatty acids are present 
in the oral mucosa and saliva. They are produced by either the oral epithelium or sebaceous glands. Due to their 
antimicrobial activity, recent work suggested that these lipids are also likely involved in innate immune defense 
against mucosal microorganisms.
The nasopharynx is the site of colonization by meningococci and the primary site of invasion prior to the 
development of systemic infection, such as sepsis and meningitis. Meningococci adhere to the nasopharyngeal 
mucosa via interactions between the human epithelial cells and a variety of adhesins and invasins 31–36. It is likely 
that a number of factors that contribute to the integrity of the mucosal barrier and prevent both colonization 
and invasion and antimicrobial lipids may probably play a role in preventing colonization and invasion of these 
bacteria. We have recently analyzed the antimicrobial properties of sphingolipids against N. meningitidis13, 
including sphingosine, short-chain  C6 and long-chain  C16-ceramides as well as azido-functionalized ceramide 
analogs. We found that treatment with sphingosine, short-chain  C6 ceramide and ω-N3-C6-ceramide lead to 
efficient killing of N. meningitidis13. Of note, short-chain  C6 ceramide and ω-N3-C6-ceramide were inactive 
against E. coli and S. aureus13. Here, we now extended the findings of our previous study and included an azido-
functionalized sphingosine to determine its antimicrobial activity against N. meningitidis. ω-N3-Sphingosine 
displayed significant antimicrobial activity against N. meningitidis, and MIC/MBC values were comparable to 
MIC/MBC values displayed for the unmodified sphingosine.
However, while the inhibitory activity of those antimicrobial sphingolipids has been investigated for a longer 
time, using biological approaches by us and other  researchers3,4,13, the exact mechanism of the antibacterial 
activity on the bacterial cell was only recently investigated for the natural  sphingosine14. The authors showed 
a massive increase in membrane permeability in Pseudomonas aeruginosa and S. aureus after treatment with 
sphingosine and linked this to the interaction between the protonated form of the sphingosine  NH2 group 
and the highly negatively charged bacterial membrane lipid cardiolipin. However, because ceramides including 
ω-N3-C6-ceramide lack this specific  NH2 group, due to the fatty acid side chain, the mode of action of ω-N3-C6-
ceramide remained elusive.
Gram-positive bacteria are characterized by having a cytoplasmatic membrane and a thick peptidoglycan 
cell wall, which confers the characteristic cell shape and provides the cell with mechanical  protection37. Gram-
negative bacteria such as the β-proteobacterium N. meningitidis are characterized by the presence of two distinct 
membranes, called inner and outer membrane and a thin peptidoglycan cell wall between  them37. The bacterial 
cell membranes are mainly formed by polar lipid bilayers (e.g. phospholipids) and it is likely that sphingolipids 
may insert into the outer membrane or the cytoplasmatic membrane of Gram-negative bacteria. Insertion into 
bacterial membranes may directly change the physical properties of the bacterial membrane and render the 
membrane non-functional. Alternatively, sphingolipids may penetrate and accumulate in the cytoplasm and 
may interfere with the cell metabolism. To address the question of the mode of action, electron microscopy (EM) 
has been widely used to visualize the antibacterial activity of antimicrobial lipids by determining morphologi-
cal changes after treatment of bacteria with the respective antimicrobial lipid. Most studies utilize transmission 
electron microscopy (TEM) for imaging the effects of  lipids38–43, since this technique allows the characterization 
of surface morphology along with the density of inner cytoplasmatic constituents, presence of fibers or cell vacu-
olization. Here we first visualized the effect of two azido-modified sphingolipids on N. meningitidis by scanning 
electron microscopy (SEM) and TEM. Treatment of N. meningitidis with 0.1 × MBC of both compounds showed 
strong elongation of the outer membrane, however the cell wall and intracellular content were intact. When N. 
meningitidis were treated with 1 × MBC of both compounds, bacteria showed different stages of disintegration 
and lysis. The cytoplasm was not uniform with flocculation and aggregation of intracellular contents. Bacteria 
showed electron dense intracellular inclusion bodies and additional vesicles that filled the intracellular content. 
Interestingly, our results are in line with recent published data observed for E. coli and S. aureus after treatment 
with different sphingoid  bases12. In a study by Fischer and colleagues the authors examined the effects of differ-
ent sphingoid bases, including sphingosine, dihydrosphingosine and phytosphingosine, on E. coli and S. aureus 
in detail by TEM and  SEM3,12. Sphingosine treated cells of both E. coli and S. aureus contained electron dense 
intracellular bodies similar to treatment with the azido-modified sphingosine as reported in our study. Moreover, 
treatment of E. coli with unmodified sphingosine resulted in surface bleb formation, while the cell wall appeared 
to be  intact12. Our results observed for treatment of S. aureus with the azido-modified sphingosine is also similar 
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to those obtained when cells are treated with the unmodified sphingosine: bacteria are also in various stages of 
disintegration and lysis and cellular debris are clearly visible near damaged  cells12.
It is interesting to note that azido-modified ceramides had no growth inhibitory effect on E. coli or S. aureus13. 
In case of S. aureus, this finding might be explained due to the fact that azido-modified ceramides initially 
integrate into the outer membrane—which is absent in Gram-positive bacteria—to exhibit toxic effects or that 
azido-modified ceramides cannot pass the thick peptidoglycan cell wall to interact with the cytoplasmatic layer. 
In case of E. coli, we tested the hypothesis that due to the presence of the complex glycolipid, the lipopolysac-
charide (LPS), in the outer leaflet of the lipid bilayer, azido-modified ceramides may be hindered to intercalate 
into the outer membrane. In contrast to E. coli, N. meningitidis expresses a lipooligosaccharide (LOS), lacking the 
O-antigen of the classical  LPS44. We therefore tested an E. coli K12 strain MG1655, lacking the O-antigen45,46 for 
its susceptibility to treatment with azido-modified ceramides and determined MIC and MBC values. For E. coli 
K12 strain MG1655, lacking the O-antigen, MIC/MBC values ˃ 64 µg/ml were determined and demonstrated 
that bacteria are still resistant (Table S1).
Antibody based CLEM approaches for precise localization of epitopes of interest in the ultrastructural context 
combine the advantages of light and electron microscopy. Said that, often the limit is the antibody itself due to 
multitude of possible technical obstacles, such as weakness of interaction in the EM-sample preparation steps, 
pure size of the antibody that hinders precise localization or, in the worst case, complete lack of a suitable anti-
body for a given epitope. The click-chemistry approach paves the way to circumvent several of these obstacles 
of antibody based CLEM approaches as successfully shown for click-labelling on  cryosections47. Although a big 
breakthrough in CLEM, labelling of sections, be it cryo or resin-sections, is often laborious and technically chal-
lenging. To circumvent these limits of on-section labelling, we established a novel pre-embedding labelling pro-
tocol based on super-resolution array tomography (srAT)17,18,25,26 and click chemistry  reaction19 for fluorescence 
and electron imaging of azido-modified sphingolipid analogs on N. meningitidis. The improved srAT-CLEM 
approach (Click-AT-CLEM), developed for this study, combines the strength of classical AT-CLEM protocols 
with the advantages of click  chemistry18,48. The possibility of epitope localization within the EM resolution range 
is strongly improved by the unmatched specificity of click chemistry reactions. In the classical, antibody-based 
AT approach, post fixation and embedding staining leads to a reduction of accessible  epitopes27. Due to the pre-
fixation and embedding staining in the novel Click-srAT protocol, we achieved an accessibility of all surface 
epitopes thus leading to an improved signal with less hand on time.
Our CLEM studies confirmed the results of the morphological studies und clearly showed the incorpora-
tion of azido-modified sphingolipids into the outer membrane of N. meningitidis. This novel pre-embedding 
Click-srAT protocol has the advantage that it can be combined with post-embedding antibody staining as in 
classical AT and srAT. This adds another level of versatility to our novel approach. Notably, as the clicked dye is 
integrated within the sections and not only on the surface the strength of the signal can be increased by turning 
to thicker sections if the detection of the signal is limiting and thereby adding up signal throughout the thick-
ness of the section. Furthermore, also the fluorescent channels could be potentially switched or even combined 
in a multi-channel pre-embedding labelling approach, as we could show that also rhodamine stays fluorescent 
in the LR-White resin throughout the embedding  steps49. An important point in qualitive experiments, like the 
established Click-AT-CLEM approach, is the proof of observation by quantitative experiments. For that purpose, 
we successfully separated the inner (fractions 1–4) and outer membrane (fractions 8–12) of N. meningitidis after 
treatment with the functionalized lipids, as shown by the comparison of LDH activity and OpcA abundance, and 
used these samples for mass spectrometric analyses (Fig. 5). The results clearly showed a pronounced increase in 
concentration with fraction 9 being the one with the highest observed amount of both functionalized sphingolip-
ids. Remarkably, this fraction appeared to be the cleanest outer membrane fraction with a strong OpcA signal and 
the lowest LDH activity. These results confirm our observations during the Click-AT-CLEM observations and 
emphasize the primary effect of the outer membrane during low concentration treatment. This novel approach 
complements biological approaches, such as growth inhibitory assay and SEM or TEM, and enables to decipher 
the mechanism of the antibacterial activity of sphingolipids.
Methods
Bacterial strains. Neisseria meningitidis strain MC58 (a serogroup B strain of the sequence type (ST)-74 
(ST-32 clonal complex [cc])) was used in this study. This strain was isolated in the UK (1983) and was kindly 
provided by  Moxon50. N. meningitidis MC58 was grown overnight on Columbia blood agar plates (bioMérieux) 
at 37 °C in 5%  CO2 and cultured on the next day in PPM+ (proteose-peptone medium (PPM) supplemented 
with 1 × Kellogg’s supplement, 0.01 M  MgCl2, and 0.005 M  NaHCO3 (PPM+)). E. coli (ATCC 25922, Serotype 
06; Biotype 1), E. coli K12 (MG1655) and S. aureus (ATCC 29213, subspecies aureus Rosenbach) were cultivated 
overnight at 37 °C with shaking in lysogenic broth (LB) for E. coli or tryptic soy broth (TSB) for S. aureus liquid 
culture.
Lipids. d-erythro-Sphingosine was purchased from Santa Cruz Biotechnology (Heidelberg, Germany). 
ω-N3-C6-ceramide (d18:1/6:0-ω-N3) (6-azido-N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)hexanamide) was 
synthesized by amide coupling of sphingosine according to  literature16. ω-N3-sphingosine ((2S,3R,E)-2-amino-
18-azidooctadec-4-ene-1,3-diol) was chemically synthesized as previously  described22. All lipids were dissolved 
in pure ethanol and stored at − 20 °C.
Antimicrobial assay. Minimal inhibitory and bactericidal concentration (MIC and MBC) values were esti-
mated using broth microdilution assay. The assays were performed as described elsewhere with minor  changes13. 
Briefly, lipids were geometrically diluted in either PPM+ for N. meningitidis or Müller-Hinton broth (Difco Labo-
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ratories) for E. coli and S. aureus. Concentrations from 128 to 1 µg/ml were diluted 1:1 with 1 × 108 bacteria/ml in 
the corresponding medium resulting in test concentration ranging from 64 to 0.5 µg/ml. At concentration higher 
than 64 µg/ml the lipids had an optical density that interfered with the determination of the MIC. Plates were 
incubated for 16 h at 37 °C and 5%  CO2 (for N. meningitidis) and 37 °C (for S. aureus and E. coli). Afterwards, the 
optical density of bacterial growth was read at 540 nm in a spectrophotometer (Infinite F200 Pro Reader, Tecan 
Group, Maennedorf, Switzerland) or MIC was directly read from the plate. The MIC was defined as the lowest 
concentration at which no visible growth occurs, and the MBC was defined as the concentration of lipid that 
prevented growth. Quality control was monitored with E. coli ATCC 25922 and S. aureus isolates ATCC 29213.
Transmission electron microscopy (TEM). 1 × 109 bacteria from a pre-culture were inoculated into 
10 ml of fresh PPM+ containing either 0.1 or 1 × the MBC concentration of the compound tested. After 3 h of 
incubation at 37 °C in a shaking incubator, the bacteria were harvested for 15 min at 4000g. The pellet was then 
washed once with phosphate buffered saline (PBS), resuspended in 100 µl of fixation solution (2.5% glutaral-
dehyde in 50 mM cacodylate buffer), centrifuged and incubated for 1 h at room temperature (RT). Afterwards, 
the bacteria pellet was washed 5 times (15 min per wash) with cacodylate buffer (50 mM KCl, 2.5 mM  MgCl2, 
50 mM cacodylate, pH 7.2) and post fixed with osmium tetroxide (2%  OsO4 in cacodylate buffer) for 2 h. After 
5 washing steps with water, additional en bloc contrast was achieved by incubating the samples in 0.5% uranyl 
acetate (in  dH2O) overnight. Following 5 washing steps, the samples were dehydrated in a gradient of increasing 
ethanol concentrations (50, 70, 90% in  H2O and 3 × 100%; 30 min each) and subsequent incubation in 100% 
propylene oxide (two times, 30 min each). The samples were infiltrated with 50% Epon resin in propylene oxide 
overnight. Next, they were transferred to 100% Epon which was changed two times after 2 and 4 h and cured at 
60 °C for 48 h. Ultrathin sections (70 nm) were cut using the Leica EM UC7 ultramicrotome, contrasted with 
uranyl acetate and lead citrate following a standard procedure and images were taken with the JEOL JEM-2100 
transmission electron microscope (JEOL Germany, Freising, Germany) at 200 kV. Images were recorded with a 
TemCam-F416 (TVIPS, Gauting, Germany) digital camera.
Scanning electron microscopy (SEM). Bacteria were treated as described above. After incubation with 
the compounds, bacteria were harvested, resuspended in 1 ml PPM+ and applied to poly-l-lysine coated round 
cover glasses for 2 h. The supernatant was then removed and the cover glasses were washed once with 1 ml PBS. 
Afterwards, fixation was performed with 6.25% glutaraldehyde in Sörensen buffer (pH 7.4: 82 ml of 133 mM 
 Na2HPO4 in water, filled up to 100 ml with 133 mM  KH2PO4) overnight at 4 °C. After 5 washing steps with 
Sörensen buffer, the samples were dehydrated with increasing acetone concentrations (30, 50, 75, 90% in  H2O 
and 100%, 30 min each). Then, critical point drying was performed using the Critical Point Dryer CPD030 
(Baltec). The dried samples were coated with a thin gold–palladium (80:20) coating using the Sputter Coater 
SCD005 (Baltec). Images were taken with the JSM-7500F scanning electron microscope (JEOL Germany, Freis-
ing, Germany).
Correlative light and electron microscopy (CLEM) and click chemistry. The CLEM workflow was 
adapted from the super-resolution array tomography protocol (srAT) described  previously17,18 with certain 
changes. Bacteria were grown and treated as described in the TEM methods section. Afterwards, the cell pellet 
was resuspended in 100 µl of 5 µM Dibenzocyclooctyne-amine Alexa Fluor 488 (DBCO-AF488; Jena Bioscience, 
Germany) and the click reactions between the functional azide group of the lipid and the functional DBCO 
group of the dye took place at 37 °C for 15 min. After washing once with PBS, the pellet was fixed in 4% for-
maldehyde (in PBS) for 1 h at RT. The pellet was washed 5 times in PBS and incubated in ammonium chloride 
(50 mM ammonium chloride in PBS) for 15 min. Following several washes in water, the samples were embedded 
in LR White resin according to the following Progressive Lowering of Temperature (PLT) protocol. The initial 
dehydration step of 30% ethanol in water happens on ice (2 × 15 min), then the following steps (50%, 70% (with 
0.2% uranyl acetate), 90% (with 0.2% uranyl acetate) and 100% ethanol; 2 times 30 min each) at -20 °C. A mix-
ture of 100% ethanol and LR White (1:1) was incubated overnight and resin infiltration was performed within 
24 h, with washes after 1 h, 4 h, 20 h and 24 h at 4 °C. The resin was polymerized at 42 °C for 3 days. Ultrathin 
sections (100 nm) were transferred onto a poly-l-lysine coated microscopy slide and stained with the DNA dye 
methyl green (1:10,000 in  dH2O from a 2% stock in water) for 10 min, rinsed off and mounted in Mowiol and 
high precision cover  glasses51. Fluorescence images were acquired using the Elyra S.1 SIM (Zeiss, Germany). 
The samples were then processed for imaging at the SEM by removing the cover glass, washing off the mounting 
medium and contrasting with heavy metals as follows: the sections are first incubated in 2.5% uranyl acetate in 
ethanol for 15 min and in 50% lead citrate in  H2O (according to Reynolds’ 52) for 10 min. Carbon coating was 
performed with the Compact Coating Unit CCU-010 (Safematic, Bad Ragaz, Switzerland) resulting in a ca. 3 nm 
coating. Images were taken with the JSM-7500F scanning electron microscope (JEOL USA, Inc., Peabody, MA 
USA).
Registration of the fluorescence and electron microscopy images was accomplished with Inkscape 0.91 (Ink-
scape Community) using the heterochromatin pattern as an intrinsic landmark in both channels (for a detailed 
description  see17,18. For an unbiased correlation the channel of interest (lipid signal) was hidden and only the 
DNA signal was used. After the correlation the channel of interest was revealed, and all channels could be merged.
Neisserial membrane separation. Membrane separation of the meningococcal outer and inner mem-
brane (OM/IM) was performed with minor changes, as previously  described53. Briefly, either ω-N3-C6-ceramide, 
ω-N3-sphingosine or a corresponding amount of EtOH were added to a final concentration of 0.1 × the MBC 
to 100 ml cultures of N. meningitidis strain MC58 with an OD600 of 0.1. After 3 h of incubation at 37 °C in an 
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orbital shaker, bacteria were harvested and washed three times with PBS and in the end resuspended in 50 mM 
Tris–HCl (pH 8). Afterwards, lysozyme (100 µg/ml) and EDTA (pH 8, 5 mM) were added and the bacteria were 
incubated for 1 h at RT while shacking. This step was followed by one freeze thaw cycle (− 80 °C to 37 °C) and 
sonication (10 s pulses with 5 s breaks, at 100% magnitude for a total of 5 min). Unbroken bacteria were removed 
by centrifugation at 1200g and 4 °C for 10 min. Then, the supernatant was loaded on top of a sucrose gradient, 
consisting of a 3 ml 15% top layer over a 2 ml 55% cushion (both with 5 mM EDTA pH 8), and centrifuged at 
280,000g and 4 °C for 2 h. The crude membrane fraction was then collected, the sucrose concentration estimated 
with a refractometer and lowered to 30% by dilution with  dH2O (with 5 mM EDTA, pH 8). Afterwards, the 
sample was loaded onto a sucrose gradient consisting of 1.3 ml 50% cushion and 45, 40, 35% layer on top (2.4 ml 
each). The gradient was then centrifuged for 41 h at 268,000g and 4 °C and afterwards 800 µl samples were col-
lected from top to bottom.
Then, the purity of the isolated OM and IM fraction was analyzed. Lactate dehydrogenase (LDH) was chosen 
as inner membrane  marker54 and the presence of the meningococcal OpcA protein as outer membrane marker. 
LDH was determined with a commercial LDH activity assay and used according to the manufacturer’s instruc-
tions (Sigma Aldrich). Activity was calculated as LDH activity/µg protein (determined by Bradford assay). To 
visualize the relative amount of OpcA in the samples, the protein amounts were adjusted and utilized in a dot blot 
assay with a monoclonal mouse anti-OpcA antibody (clone B306, kindly provided by M. Achtman). 4 µl of each 
sample was spotted onto a nitrocellulose membrane. After drying, nonspecific binding sites were blocked with 
5% skim milk in PBS supplemented with 0.05% Tween 20 (PBS-T) for 1 h at RT on an orbital shaker. Afterwards, 
primary antibody incubation was carried out with a 1:10,000 dilution of the anti-OpcA antibody for 30 min 
followed by three washing steps with PBS-T (5 min each). For secondary antibody incubation, an anti-mouse 
IgG antibody, conjugated to horseradish peroxidase (HRP), was used with a 1:1000 dilution in 5% skim milk in 
PBS-T. After 30 min incubation at RT, the membrane was washed again three times with PBS-T and once with 
PBS for 5 min each. Finally, ECL substrate (BioRad) was added for 1 min and the protein was visualized using 
the ChemiDoc MP Gel and Blot Imaging System (BioRad).
Quantification of azido‑functionalized sphingolipid derivatives by HPLC–MS/MS. Samples of 
neisserial membrane fractionation (600 µl) were filled up with water to 1 ml followed by addition of 110 µl 
10 × Baker buffer (300 mM citric acid, 400 mM disodium hydrogen phosphate, pH 3.0). For lipid extraction, 
2 ml 1-butanol and 1 ml water-saturated 1-butanol were added. The extraction solvent contained sphingosine-
d7 (Sph-d7), sphingosine 1-phosphate-d7 (S1P-d7), C17 ceramide (C17 Cer) and C16 sphingomyelin-d31 (C16 
SM-d31) (all Avanti Polar Lipids, Alabaster, USA) as internal standards. Extraction was facilitated by intensive 
vortexing (1500 rpm) for 10 min at RT. Afterwards, samples were centrifuged for 5 min at 2200g (4 °C). The upper 
organic phase was dried under reduced pressure using a Savant SpeedVac concentrator (Thermo Fisher Scien-
tific, Dreieich, Germany). Dried residues were reconstituted in 200 μl acetonitrile/methanol/water (47.5:47.5:5 
(v:v:v), 0.1% formic acid) and subjected to HPLC–MS/MS sphingolipid quantification. Chromatographic sepa-
ration was achieved on a 1260 Infinity HPLC (Agilent Technologies, Waldbronn, Germany) equipped with a 
Poroshell 120 EC-C8 column (3.0 × 150 mm, 2.7 µm; Agilent Technologies) guarded by a pre-column of identical 
material. MS/MS analysis was carried out using a 6490 triple-quadrupole mass spectrometer (Agilent Technolo-
gies) operating in the positive electrospray ionization mode (ESI+). Long-chain bases (dihydro-Sph, Sph, S1P), 
Cer and SM species (C16, C18, C20, C22, C24 and C24:1) were analyzed by selected reaction monitoring (SRM) 
as described  recently55. Additionally, the following mass transitions were recorded for quantification of func-
tionalized sphingolipids (collision energies (CE) in parentheses): m/z 341.3 → 323.3 for ω-N3-Sph (8 eV) and 
m/z 439.4 → 421.4 (15 eV), m/z 439.4 → 282.3 (25 eV), m/z 421.4 → 264.3 (25 eV, quantifier) for ω-N3-C6 Cer 
(d18:1/6:0-ω-N3). Sph-d7 and C17 Cer served as internal standards for quantification of ω-N3-Sph and ω-N3-C6 
Cer, respectively. Moreover, quantities of azido-functionalized sphingolipid derivatives were normalized to the 
C16 SM (SM d18:1/16:0) content of each membrane fraction analyzed. Data processing was performed with 
MassHunter Software (Agilent Technologies).
Statistical analysis. Statistical analysis was performed with GraphPad Prism 6 (GraphPad Software Inc., 
La Jolla, CA, USA) by analysis of variance (ANOVA) test followed by a post hoc test. Asterisks indicate signifi-
cance values: *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
Data availability
All data generated or analyzed during this study are available from the author on reasonable request.
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